Cargando…
The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis
BACKGROUND: To evaluate the benefit of second-line chemotherapy with platinum-based treatment in patients with recurrent small cell lung cancer (SCLC). PATIENTS AND METHODS: A total of 535 patients continued with follow-up or best supportive care if needed, and 229 patients who progressed after the...
Autores principales: | Zarogoulidis, Konstantinos, Boutsikou, Efimia, Zarogoulidis, Paul, Darwiche, Kaid, Freitag, Lutz, Porpodis, Konstantinos, Latsios, Dimitrios, Kontakiotis, Theodoros, Huang, Haidong, Li, Qiang, Hohenforst-Schmidt, Wolfgang, Kipourou, Maria, Turner, J Francis, Spyratos, Dionysios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808208/ https://www.ncbi.nlm.nih.gov/pubmed/24174880 http://dx.doi.org/10.2147/OTT.S52330 |
Ejemplares similares
-
New dilemmas in small-cell lung cancer TNM clinical staging
por: Zarogoulidis, Konstantinos, et al.
Publicado: (2013) -
Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a Phase II, randomized study
por: Zarogoulidis, Konstantinos, et al.
Publicado: (2013) -
Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer
por: Boutsikou, Eftimia, et al.
Publicado: (2013) -
Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy
por: Domvri, Kalliopi, et al.
Publicado: (2013) -
Predictive Value of 99MTC-hynic-toc Scintigraphy in Lung Neuroendocrine Tumor Diagnosis
por: Boutsikou, Efimia, et al.
Publicado: (2019)